InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Friday, 02/27/2015 10:04:44 AM

Friday, February 27, 2015 10:04:44 AM

Post# of 80867
perhaps we should give Musclepharm a break on the late announcement of q4 results.

Musclepharm is undergoing a SEC investigation and the company is in a major adjustment after it decided to sell through Walmart and Sam's Club. This adjustment will not help the bottom line in the short term.

We should probably worry more about the qualities of the CFO and the cash at hand than when Musclepharm announces it results while adjusting to larger revenues and lower margins.